KAKKIS EMIL D Insider Trading Activity

Average Profitability
8.24%
Insider Buys Quantity
8
Insider Buys Sum
$775,274.64
Insider Sells Quantity
41
Insider Sells Sum
$53.42M

Insider Activity of KAKKIS EMIL D

According to the SEC Form 4 filings, KAKKIS EMIL D, being in a position of

  1. President & CEO at Ultragenyx Pharmaceutical Inc.,
    оver the last 12 months, has bought 0 shares, and sold 54404 shares for $1.24M,
    over all time since 2015-10-30, has bought 12500 shares for $612,072, and sold 713163 shares for $48.4M.

Biography of KAKKIS EMIL D

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,240,4111100

Comparison of Insiders on Amount of Buys and Sells

2026-03-02SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
54,404
0.0549%
$22.80$1.24M+3%
2025-03-03SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
73,434
0.0813%
$42.10$3.09M-20.43%
2025-02-28SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
25,000
0.0271%
$42.48$1.06M-23.42%
2024-12-30SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
11,727
0.0124%
$42.23$495,231-17.09%
2024-12-10SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
8,273
0.0092%
$50.00$413,650-27.88%
2024-09-03SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
20,000
0.0218%
$55.85$1.12M-27.92%
2024-08-06SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
20,000
0.0223%
$50.17$1M-14.63%
2024-02-07SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0366%
$45.00$1.35M+4.2%
2023-12-29SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0365%
$47.87$1.44M-2.17%
2023-10-19SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
47,853
0.0673%
$33.52$1.6M+34.95%
2022-12-30SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
19,582
0.0275%
$45.57$892,352-9.48%
2021-05-03SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0449%
$107.80$3.23M-22.34%
2021-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0445%
$141.80$4.25M-38.37%
2021-01-04SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0448%
$136.90$4.11M-29.67%
2020-11-02SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.047%
$96.82$2.9M+11.64%
2020-09-01SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
30,000
0.0496%
$82.63$2.48M+29.59%
2020-07-13SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
40,000
0.0686%
$85.35$3.41M+30.14%
2019-09-11PurchaseUltragenyx Pharmaceutical Inc.
RARE
President & CEO
5,000
0.0084%
$43.63$218,150+26.68%
2019-03-05SaleUltragenyx Pharmaceutical Inc.
RARE
President & CEO
2,890
0.0054%
$65.52$189,353-13.14%
2017-08-28PurchaseUltragenyx Pharmaceutical Inc.
RARE
President & CEO
7,500
0.0175%
$52.52$393,922-0.07%
Total: 50
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.